MOLECULAR PARTNERS AG -ADR (MOLN) Stock Analyst Ratings
USA - NASDAQ:MOLN - US60853G1067 - ADR
3.91 USD
-0.17 (-4.28%)
4.07 USD
+0.16 (+4.09%)
ChartMill assigns a Buy % Consensus number of 82% to MOLN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.8. This target is 252.98% above the current price.
MOLN was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MOLN.
In the previous month the buy percentage consensus was at a similar level.
MOLN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-03-11 | LifeSci Capital | Initiate | Outperform |
| 2023-12-05 | JP Morgan | Maintains | Neutral -> Neutral |
| 2022-08-29 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-25 | Credit Suisse | Upgrade | Underperform -> Neutral |
| 2022-04-27 | SVB Leerink | Maintains | Outperform |
| 2022-01-14 | SVB Leerink | Maintains | Outperform |
| 2021-08-27 | SVB Leerink | Maintains | Outperform |
MOLECULAR PARTNERS AG -ADR / MOLN FAQ
What is the average price target for MOLECULAR PARTNERS AG -ADR (MOLN) stock?
9 analysts have analysed MOLN and the average price target is 13.8 USD. This implies a price increase of 252.98% is expected in the next year compared to the current price of 3.91.
What is the consensus rating for MOLECULAR PARTNERS AG -ADR (MOLN) stock?
The consensus rating for MOLECULAR PARTNERS AG -ADR (MOLN) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for MOLN stock?
The number of analysts covering MOLECULAR PARTNERS AG -ADR (MOLN) is 9.